SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging
vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-…

The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide …

Coronavirus disease 2019 (COVID-19) was first diagnosed in Scotland on 1 March 2020.
During the first month of the outbreak, 2,641 cases of COVID-19 led to 1,832 hospital …

SARS-CoV-2 can mutate to evade immunity, with consequences for the efficacy of emerging
vaccines and antibody therapeutics. Herein we demonstrate that the immunodominant …

Next-generation sequencing (NGS) technologies have dramatically expanded the breadth
of genomics. Genome-scale data, once restricted to a small number of biomedical model …

Human cytomegalovirus (HCMV) extensively modulates host cells, downregulating >900
human proteins during viral replication and degrading ≥133 proteins shortly after infection. …

Human cytomegalovirus (HCMV) is a major human pathogen whose life-long persistence is
enabled by its remarkable capacity to systematically subvert host immune defenses. In …

We have developed periscope, a tool for the detection and quantification of subgenomic
RNA (sgRNA) in SARS-CoV-2 genomic sequence data. The translation of the SARS-CoV-2 …

The pandemic spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
the etiological agent of Coronavirus Disease 2019 (COVID-19), represents an ongoing …

Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of intrinsic,
innate, and adaptive viral immune evasion. Here, we employed multiplexed tandem mass …